跳至主要内容
临床试验/NCT06796738
NCT06796738进行中(未招募)不适用

Advancing Cervical Cancer Screening Through the Emergency Department

University of Rochester1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2025年6月13日最近更新:
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
200
试验地点
1
主要终点
Uptake of Cervical Cancer Screening

研究概览

简要总结

Cervical cancer screening in the Emergency Department

详细描述

This will be an effort to deploy HPV self-sampling among Emergency Department patients. Emergency Department patients, in the US and worldwide, are disproportionally under-screened for cervical cancer relative to the general population.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
25 Years 至 65 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Cisgender women and transgender/non-binary individuals with a cervix,
  • Age 25-65,
  • Able to demonstrate decisional capacity to participate.

排除标准

  • Past hysterectomy with cervical removal,
  • Known infection with HIV (as screening recommendations for people with HIV differ from the general population),
  • Non-English speaking.

研究组 & 干预措施

Intervention Arm - testing

Other

Participants in this arm will be provided the opportunity to self- sample for HPV during their ED visit. Participants will be (1) briefly instructed by the study staff on how to self-sample using a defined instructional script written at an elementary reading level, (2) provided with a packaged swab and vial of transport media, and (3) invited to self- sample privately in their ED room or in one of the private ED restrooms.

干预措施: HPV testing (Diagnostic Test)

结局指标

主要结局

Uptake of Cervical Cancer Screening

时间窗: 150 days post initial intervention

All intervention participants will receive a follow-up call at 150 days to assess uptake of any cervical cancer screening and for completion of the cervical cancer screening process. "Any cervical cancer screening" is defined as uptake of any aspect of the cervical cancer screening process, including self-sampling and/or clinic-based screening. "Completion of the cervical cancer screening process" is defined as completion of recommended clinic-based screening (including colposcopy if HPV 16/18+ or indicated).

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

David Adler

Professor

University of Rochester

研究点 (1)

Loading locations...

相似试验